Found 6 matching trials
Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon
PHASE1LA rVSVΔG-ZEBOV-GP -02-PED is a Phase 1/2, randomized, controlled open labe...
Location
Centre de Recherches Médicales de Lambaréné
Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy
N/AThe goal of this observational study is to learn about vaccine immunity in ...
Location
University Hospital Bern
An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children
PHASE3The purpose of this study is to evaluate the efficacy, immunogenicity and s...
Location
GSK Investigational Site
Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM
PHASE3The purpose of this study is to assess non-inferiority of two different vac...
Location
GSK Investigational Site
Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine
PHASE3Follow-up to evaluate the immunogenicity and safety of three production lot...
Location
GSK Investigational Site
Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136
PHASE3This Phase 3b study is being conducted for the purpose of registration of t...
Location
GSK Investigational Site